NeoLight announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Skylife™ portable phototherapy system. The Skylife device delivers a narrow band of high-intensity blue light via blue light emitting diodes (LEDs) to provide treatment for neonatal unconjugated hyperbilirubinemia (jaundice).
